These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33522706)

  • 21. Therapy and prognostic significance of regional lymph node involvement in embryonal rhabdomyosarcoma: a report from the European paediatric Soft tissue sarcoma Study Group.
    Ben-Arush M; Minard-Colin V; Scarzello G; Fajardo RD; Terwisscha Van Scheltinga S; Bernier V; Jenney M; Gallego S; Zanetti I; Cesen M; Merks JHM; Bisogno G
    Eur J Cancer; 2022 Sep; 172():119-129. PubMed ID: 35763871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate: combined results from the Children's Oncology Group, German Cooperative Soft Tissue Sarcoma Study, Italian Cooperative Group, and International Society of Pediatric Oncology Malignant Mesenchymal Tumors Committee.
    Rodeberg DA; Anderson JR; Arndt CA; Ferrer FA; Raney RB; Jenney ME; Brecht IB; Koscielniak E; Carli M; Bisogno G; Oberlin O; Rey A; Ullrich F; Stevens MC; Meyer WH
    Int J Cancer; 2011 Mar; 128(5):1232-9. PubMed ID: 20473932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment and outcome of patients with localized intrathoracic and chest wall rhabdomyosarcoma: a report of the Cooperative Weichteilsarkom Studiengruppe (CWS).
    Fuchs J; Urla C; Sparber-Sauer M; Schuck A; Leuschner I; Klingebiel T; Blumenstock G; Seitz G; Koscielniak E
    J Cancer Res Clin Oncol; 2018 May; 144(5):925-934. PubMed ID: 29464349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymph node management in patients with paratesticular rhabdomyosarcoma: a population-based analysis.
    Dang ND; Dang PT; Samuelian J; Paulino AC
    Cancer; 2013 Sep; 119(17):3228-33. PubMed ID: 23744806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alveolar paratesticular rhabdomyosarcoma mimicing epididymitis: Case report and literature review.
    Lei WH; Wu WF; Zhen JY; Li YH; Li J; Xin J
    Medicine (Baltimore); 2018 Jun; 97(25):e11164. PubMed ID: 29924027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality assessment of lymph node sampling in rhabdomyosarcoma: A surveillance, epidemiology, and end results (SEER) program study.
    Lobeck I; Dupree P; Karns R; Rodeberg D; von Allmen D; Dasgupta R
    J Pediatr Surg; 2017 Apr; 52(4):614-617. PubMed ID: 27642084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Local recurrence of paratesticular rhabdomyosarcoma].
    Rabii R; Moufid K; Fekak H; Dassouli B; Joual A; Bennani S; el Mrini M; Benjelloun S
    Ann Urol (Paris); 2002 Oct; 36(5):326-8. PubMed ID: 12481625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paratesticular rhabdomyosarcoma (RMS) and paraaortic lymphadenectomy.
    Gamba PG; Cecchetto G; Katende M; Carli M; Sotti G; Guglielmi M
    Eur J Pediatr Surg; 1994 Jun; 4(3):158-60. PubMed ID: 8086392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Paratesticular rhabdomyosarcoma. Report of a case and review of the literature].
    Guinda Sevillano C; Borrego Hernando J; Laguna Pés P; Gimeno Collado A; Zazo Romojaro A; Amigo Echenagusia A
    Actas Urol Esp; 1998 Sep; 22(8):690-4. PubMed ID: 9835091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on pediatric rhabdomyosarcoma: A report from the APSA Cancer Committee.
    Rhee DS; Rodeberg DA; Baertschiger RM; Aldrink JH; Lautz TB; Grant C; Meyers RL; Tracy ET; Christison-Lagay ER; Glick RD; Mattei P; Dasgupta R;
    J Pediatr Surg; 2020 Oct; 55(10):1987-1995. PubMed ID: 32674846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is alveolar histotype a prognostic factor in paratesticular rhabdomyosarcoma? The experience of Italian and German Soft Tissue Sarcoma Cooperative Group.
    Ferrari A; Bisogno G; Casanova M; Brecht IB; Alaggio R; Cecchetto G; Provenzi M; Koscielniak E; Treuner J; Carli M
    Pediatr Blood Cancer; 2004 Feb; 42(2):134-8. PubMed ID: 14752876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging in rhabdomyosarcoma: a patient journey.
    de Vries ISA; van Ewijk R; Adriaansen LME; Bohte AE; Braat AJAT; Fajardo RD; Hiemcke-Jiwa LS; Hol MLF; Ter Horst SAJ; de Keizer B; Knops RRG; Meister MT; Schoot RA; Smeele LE; van Scheltinga ST; Vaarwerk B; Merks JHM; van Rijn RR
    Pediatr Radiol; 2023 Apr; 53(4):788-812. PubMed ID: 36843091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re: lymph node management in patients with paratesticular rhabdomyosarcoma: a population-based analysis.
    Richie JP
    J Urol; 2014 Jun; 191(6):1785-6. PubMed ID: 25280284
    [No Abstract]   [Full Text] [Related]  

  • 34. Significance of fusion status, Oberlin risk factors, local and maintenance treatment in pediatric and adolescent patients with metastatic rhabdomyosarcoma: Data of the European Soft Tissue Sarcoma Registry SoTiSaR.
    Heinz AT; Schönstein A; Ebinger M; Fuchs J; Timmermann B; Seitz G; Vokuhl C; Münter M; Pajtler KW; Stegmaier S; von Kalle T; Kratz CP; Ljungman G; Juntti H; Klingebiel T; Koscielniak E; Sparber-Sauer M;
    Pediatr Blood Cancer; 2024 Jan; 71(1):e30707. PubMed ID: 37814424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paratesticular pleomorphic rhabdomyosarcoma in an adult.
    Demir A; Onol FF; Türkeri L
    Int Urol Nephrol; 2004; 36(4):577-8. PubMed ID: 15787340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indications for hemiscrotectomy in the management of genitourinary tumors in children.
    Rogers DA; Rao BN; Meyer WH; Pappo A; Lobe TE; Fleming ID; Kauffman WM
    J Pediatr Surg; 1995 Oct; 30(10):1437-9. PubMed ID: 8786482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neglected scrotal trauma revealing embryonic paratesticular rhabdomyosarcoma: about a case].
    Ahsaini M; Mellouki A; Ouattar K; Azelmad H; Mellas S; Ammari J; Tazi MF; Fassi MJ; Farih MH
    Pan Afr Med J; 2018; 30():107. PubMed ID: 30364355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patients with completely resected nongenitourinary low-risk embryonal rhabdomyosarcoma are candidates for reduced duration low-intensity chemotherapy.
    Bisogno G; Fuchs J; Dasgupta R; Ferrari A; Haduong JH; Rogers T; Walterhouse DO; Coppadoro B; Xue W; Vokuhl C; Hawkins DS; Seitz G; Merks JHM; Sparber-Sauer M; Venkatramani R
    Cancer; 2022 Dec; 128(23):4150-4156. PubMed ID: 36250420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Paratesticular rhabdomyosarcoma. A case report].
    Benchekroun A; Lachkar A; Soumana A; Farih MH; Belahnech Z; Marzouk M; Faik M
    Ann Urol (Paris); 1998; 32(2):107-10. PubMed ID: 9599643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paratesticular sarcoma in childhood and adolescence. A report from the Intergroup Rhabdomyosarcoma Studies I and II, 1973-1983.
    Raney RB; Tefft M; Lawrence W; Ragab AH; Soule EH; Beltangady M; Gehan EA
    Cancer; 1987 Nov; 60(9):2337-43. PubMed ID: 3440240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.